Early registration deadline: The 2014 Pregnancy Summit

Monday, 06 October 2014 09:30 – Wednesday, 08 October 2014 17:00
This year our pregnancy summit will discuss our current understanding of pre-eclampsia research and treatments.  The last day will focus on the technologies currently available to assess pregnancy and pregnancy-associated conditions. This event has CPD accreditation.

Who Should Attend
Anyone working in the field of pregnancy and diagnosing pregnancy-related illnesses and pregnancy outcome will find this event beneficial.  This includes Scientists,Obstetricians, Gynaecologists, Midwives, Clinical Chemists and Pharmaceutical and Medical devices professionals.

This event has an open poster session.  Posters can be submitted on any subject related to pregnancy

The deadline for abstract submissions for oral presentation is July 10th 2014. Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at 

Program Outline

Day 1: Pre-eclampsia research

Day 2: Pre-eclampsia treatment and management

Day 3: Technologies to assess pregnancy and pregnancy-associated conditions. 


Talks Include:
How can biomarkers be used to improve the management of pre-eclampsia
Professor Andrew Shennan, Kings College London, UK 

Preeclampsia Human Placental Model

Professor Nandakumaran Moorkath, Faculty of Medicine, University of Kuwait

Stress, immune system functioning and perinatal depression: the impact of heightened systemic inflammation and risk of CVD later in life. Is pre-eclampsia the right model
Professor Meir Steiner, 
Professor Emeritus,  McMaster University, Ontario, Canada

Placental Syncytiotrophoblast Vesicles In Normal Pregnancy And Pre-Eclampsia
Dr Dionne Tannetta,
 Senior Research Scientist, University of Oxford, UK

Central aortic pulse wave analysis parameters – a novel marker in prediction of  hypertensive complications in pregnancy
Dr Ludwina Szczepaniak-Chicheł, MD, PhD, adiunct, Dept. of Hypertensiology, Angiology and Internal Medicine, Poznan University of Medical Sciences, PolandPreeclampsia and the immune system: a close relationship 
Dr Estibalitz Laresgoit
i, Associate Professor, Attending Physician,  American British Cowdray Medical Center, Mexico, National Institute of Perinatology; Mexico, School of Medicine, Monterrey Institute of Technology and Higher Education, Mexico

Role of metabolic Syndrome factors in pre-eclampsia
Dr Shipra Sonkusare, Dept. of Obstetrics + Gynaecology,  Manipal University, India

Podocyturia as a diagnostic and prognostic marker of preeclampsia
Dr Vesna D. Garovic
, Professor of Internal Medicine, Division of Nephology+Hypertension+Dept of Obstetrics+Gynaecology, Mayo Clinic, USA

Vitamin D3 deficiency/treatment during pregnancy and complications including preeclampsia
Dr Stella Nowicki, Professor Microbiology and Immunology, Meharry Medical College, Nashville, TN, USA

The hemostatic changes in preeclampsia, is there a place for anticoagulation treatment for the prevention of this syndrome  
Professor Offer Erez
, Director of Risk Management and Patients Safty Unit, Acting Director Maternal Fetal Medicine Unit, Soroka University Medical Center, Ben Gurion University of the Negev, Israel

Anesthetic Goals of Labor Analgesia in Preeclampsia 
Dr Ayten Saracoglu,
 Assist. Prof. M.D., Department of Anesthesiology and Reanimation, Istanbul Bilim University Medical School, Turkey

Pre-eclampsia casts a long shadow
Fiona Broughton Pipkin,  Professor Emeritus of Perinatal Physiology, University of Nottingham Medical School, UK

Regional versus General Anesthesia for C/S in Severe Preeclampsia 
 Kemal Tolga Saracoglu, Assistant Professor of Anesthesiology and Reanimation, Marmara University School of Medicine Istanbul Turkey

Angiogenic Factors in Preeclampsia: Potential for Diagnosis and Treatment
Dr Sarosh Rana, MD, Assistant Professor, Harvard Medical School/ Beth Israel Deaconess Medical Center, Boston, MA, USA

Pregnancy complicated by cervical cancer
Dr Wojciech Kolawa Senior lecturer, University Hospital, Department of Gynecology and Oncology, Jagiellonian University, Krakow, Poland

Fetal haemodyanic assessment by magnetic resonance imaging
Dr Mike Seed, Pediatric Cardiologist and Radiologist, SickKids, Toronto, Canada

Was the Mona Lisa’s Smile the Result of a Pregnancy-associated Condition
Dr William Maloney, DDS, Clinical Associate Professor, New York University, USA

Information about prenatal examinations – A challenge in antenatal care

Associate Professor Susanne Georgsson Öhman
, Senior Lecturer, Karolinska Institutet Department of women’s and children’s health, Stockholm, Sweden

The role of nutrition and genetics during pregnancy
Dr Anne Parle-McDermott, Lecturer in Genetics, Dublin City University, Ireland

Catheter Ablation of Arrhythmia in Pregnant Women 
Dr John Ferguson,
 Associate Professor, University of Virginia Medical Center, USA

Additional Talks Include:
Mr Joost Schuitemaker, Managing Director, IQ Products, The Netherlands
Ms Ann Marie Barnard, Chief Executive Officer, Action on Pre-eclampsia
Dr Heather A. Boyd,   Department of Epidemiology Research, Statens Serum Institut, Denmark

Latest Euroscicon Tweets